Changing the treatment landscape of metastatic melanoma: Immunotherapies, targeted therapies and oncolytic virotherapy - 101271

Spotlight
Video

Changing the treatment landscape of metastatic melanoma: Immunotherapies, targeted therapies and oncolytic virotherapy

EMJ has 458 videos Subscribe Here

Loading........
Description: At the German Cancer Congress 2016, held in Berlin, Germany from 24 February to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany, explains that the treatment of metastatic melanoma has been revolutionised by recent developments in immunotherapeutic agents, including ipilimumab, an anti-CTLA-4 antibody, pembrolizumab, an anti-PD-1 antibody, and nivolumab, an anti-PD-1 antibody; targeted agents, including vemurafenib and dabrafenib, both BRAF inhibitors; and the oncolytic virus immunotherapy, talimogene laherparepvec (T-VEC).

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 03/02/16
Added : 3 years ago